Extremely high infiltration of CD8(+)PD-L1(+) cells detected in a stage III non-small cell lung cancer patient exhibiting hyperprogression during anti-PD-L1 immunotherapy after chemoradiation: A case report

In recent years, immune checkpoint inhibitors (ICIs), represented by PD-1/PD-L1 monoclonal antibodies, have become a research hotspot in the field of oncology treatment. Immunotherapy has shown significant survival advantages in a variety of solid tumors. However, the phenomenon of hyperprogressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Changshun, Zhou, Kai, Zheng, Yan, Lv, Dongxiao, Zhao, Miaoqing, Hu, Yue, Qi, Fei, Wang, Xin, Feng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755663/
https://www.ncbi.nlm.nih.gov/pubmed/36531043
http://dx.doi.org/10.3389/fonc.2022.969493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755663/
https://www.ncbi.nlm.nih.gov/pubmed/36531043
http://dx.doi.org/10.3389/fonc.2022.969493

Ejemplares similares